Chief Scientific Officer – Neurodegenerative

We have a a a unique opportunity to join a well-funded startup looking at new platforms and technologies to treat rare and unmet neurodegenerative and neurological diseases – particularly in pediatric patients.

Academic advisory board consists of well-known industry giants and Nobel recipients.

Read about the story here:

A Family’s Race to Cure a Daughter’s Genetic Disease

For more insight, please contact tsharon@tseworldwide.com